
Opinion|Videos|March 21, 2025
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
2
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
3
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
4
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
5
















































